Menopause

Women should be monitored to ensure they receive adequate benefit from their treatment, and counselled appropriately about individual risks. Arbitrary limits should not be placed on the duration of use of hormone therapy (HT); all patients require individualised decision making. Reassessment should occur at least annually.